Saxon Interests Inc. Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Saxon Interests Inc. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,091 shares of the healthcare conglomerate’s stock after buying an additional 243 shares during the period. Saxon Interests Inc.’s holdings in UnitedHealth Group were worth $1,034,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in UNH. Vanguard Group Inc. boosted its holdings in UnitedHealth Group by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock valued at $44,150,045,000 after purchasing an additional 250,291 shares in the last quarter. Wellington Management Group LLP boosted its holdings in shares of UnitedHealth Group by 2.1% in the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after acquiring an additional 527,526 shares during the period. Capital Research Global Investors boosted its holdings in shares of UnitedHealth Group by 2.2% in the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after acquiring an additional 324,733 shares during the period. Capital International Investors boosted its holdings in shares of UnitedHealth Group by 4.8% in the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after acquiring an additional 542,424 shares during the period. Finally, Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $5,802,231,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.7 %

UNH opened at $498.13 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market cap of $458.47 billion, a P/E ratio of 30.45, a PEG ratio of 1.48 and a beta of 0.60. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The business’s fifty day simple moving average is $498.40 and its 200 day simple moving average is $501.35.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter last year, the company earned $6.26 earnings per share. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were issued a dividend of $2.10 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a dividend yield of 1.69%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Wall Street Analyst Weigh In

Several research firms have recently commented on UNH. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 12th. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price target for the company in a research note on Wednesday, June 5th. Finally, Piper Sandler increased their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.